157 related articles for article (PubMed ID: 8463317)
1. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation.
Venable ME; Olson SC; Nieto ML; Wykle RL
J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317
[TBL] [Abstract][Full Text] [Related]
2. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
3. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
4. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
Blank ML; Smith ZL; Fitzgerald V; Snyder F
Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
6. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acceptor and donor substrates in the CoA-independent transacylase reaction in human neutrophils.
Nixon AB; Greene DG; Wykle RL
Biochim Biophys Acta; 1996 May; 1300(3):187-96. PubMed ID: 8679683
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor.
McKean ML; Silver MJ
Biochem J; 1985 Feb; 225(3):723-9. PubMed ID: 3919710
[TBL] [Abstract][Full Text] [Related]
9. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
10. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
11. Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions.
Robinson M; Blank ML; Snyder F
J Biol Chem; 1985 Jul; 260(13):7889-95. PubMed ID: 4008481
[TBL] [Abstract][Full Text] [Related]
12. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
13. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
14. Selective acyl transfer in the reacylation of brain glycerophospholipids. Comparison of three acylation systems for 1-alk-1'-enylglycero-3-phosphoethanolamine, 1-acylglycero-3-phosphoethanolamine and 1-acylglycero-3-phosphocholine in rat brain microsomes.
Masuzawa Y; Sugiura T; Sprecher H; Waku K
Biochim Biophys Acta; 1989 Sep; 1005(1):1-12. PubMed ID: 2673414
[TBL] [Abstract][Full Text] [Related]
15. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
Sugiura T; Fukuda T; Masuzawa Y; Waku K
Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
[TBL] [Abstract][Full Text] [Related]
16. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway.
Uemura Y; Lee TC; Snyder F
J Biol Chem; 1991 May; 266(13):8268-72. PubMed ID: 2022643
[TBL] [Abstract][Full Text] [Related]
17. The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism.
Baker RR; Chang HY
Mol Cell Biochem; 2000 Dec; 215(1-2):135-44. PubMed ID: 11204449
[TBL] [Abstract][Full Text] [Related]
18. Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities.
Sugiura T; Masuzawa Y; Nakagawa Y; Waku K
J Biol Chem; 1987 Jan; 262(3):1199-205. PubMed ID: 3805017
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of arachidonic acid into 1-acyl-2-lyso-sn-glycero-3-phosphocholine of the human neutrophil.
Chilton FH; Hadley JS; Murphy RC
Biochim Biophys Acta; 1987 Jan; 917(1):48-56. PubMed ID: 3098298
[TBL] [Abstract][Full Text] [Related]
20. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase.
Blank ML; Fitzgerald V; Smith ZL; Snyder F
Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
